The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis

door Egeberg, A., Gisondi, P., Carrascosa, J.M., Warren, R.B., Mrowietz, U.
Gepubliceerd in J Eur Acad Dermatol Venereol (2020)

Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.

door Schadendorf, D., Fichtner, I., Makki, A., Alijagic, S., Küpper, M., Mrowietz, U., Henz, B. M.
Gepubliceerd in 1996

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

door Reich, K., Mrowietz, U., Radtke, M. A., Thaci, D., Rustenbach, S. J., Spehr, C., Augustin, M.
Gepubliceerd in Arch Dermatol Res (2015)

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis

door Warren, R.B., Barker, J.N.W., Van de Kerkhof, P., Reich, K., Mrowietz, U.
Gepubliceerd in J Eur Acad Dermatol Venereol (2019)

The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice

door Mrowietz, U, Schwenk, U, Maune, S, Bartels, J, Küpper, M, Fichtner, I, Schröder, J-M, Schadendorf, D
Gepubliceerd in 1999

Network meta‐analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion method

door Mrowietz, U., Warren, R.B., Leonardi, C.L., Saure, D., Petto, H., Hartz, S., Dossenbach, M., Reich, K.
Gepubliceerd in J Eur Acad Dermatol Venereol (2021)

Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

door van de Kerkhof, P.C.M., Loewe, R., Mrowietz, U., Falques, M., Pau‐Charles, I., Szepietowski, J.C.
Gepubliceerd in J Eur Acad Dermatol Venereol (2019)

Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS)

door Lamprecht, P, Moosig, F, Adam-Klages, S, Mrowietz, U, Csernok, E, Kirrstetter, M, Ahmadi-Simab, K, Schroder, J, Gross, W
Gepubliceerd in 2004

A 24‐week multicentre, randomized, open‐label, parallel‐group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with modera...

door Reich, K., Augustin, M., Thaçi, D., Pinter, A., Leutz, A., Henneges, C., Schneider, E., Schacht, A., Dossenbach, M., Mrowietz, U.
Gepubliceerd in Br J Dermatol (2019)

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Stu...

door Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Lacombe, A., Xia, S., Mazur, R., Patekar, M., Charef, P., Milutinovic, M., Leonardi, C., Mrowietz, U.
Gepubliceerd in J Eur Acad Dermatol Venereol (2018)

The German National Program on Psoriasis Health Care 2005–2015: results and experiences

door Augustin, M., Eissing, L., Langenbruch, A., Enk, A., Luger, T., Maaßen, D., Mrowietz, U., Reich, K., Reusch, M., Strömer, K., Thaçi , D., von Kiedrowski, R., Radtke, M. A.
Gepubliceerd in Arch Dermatol Res (2016)

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

door Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Gepubliceerd in J Eur Acad Dermatol Venereol (2017)

ALIGNed on adherence: subanalysis of adherence in immune‐mediated inflammatory diseases in the DACH region of the global ALIGN study

door Kolios, A.G.A., Hueber, A.J., Michetti, P., Mrowietz, U., Mustak‐Blagusz, M., Sator, P.‐G., Reinshagen, M., Wilsmann‐Theis, D., Gomis‐Kleindienst, S., Luckey, U., Rössler, A., Schiefke, I.
Gepubliceerd in J Eur Acad Dermatol Venereol (2018)

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

door Jemec, G.B.E., Okun, M.M., Forman, S.B., Gulliver, W.P.F., Prens, E.P., Mrowietz, U., Armstrong, A.W., Geng, Z., Gu, Y., Williams, D.A., Teixeira, H.D., Kimball, A.B.
Gepubliceerd in Br J Dermatol (2019)

Definition of treatment goals for moderate to severe psoriasis: a European consensus

door Mrowietz, U., Kragballe, K., Reich, K., Spuls, P., Griffiths, C. E. M., Nast, A., Franke, J., Antoniou, C., Arenberger, P., Balieva, F., Bylaite, M., Correia, O., Daudén, E., Gisondi, P., Iversen, L., Kemény, L., Lahfa, M., Nijsten, T., Rantanen, T., Reich, A., Rosenbach, T., Segaert, S., Smith, C., Talme, T., Volc-Platzer, B., Yawalkar, N.
Gepubliceerd in 2010

German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)

door Nast, A., Kopp, I., Augustin, M., Banditt, K. B., Boehncke, W. H., Follmann, M., Friedrich, M., Huber, M., Kahl, C., Klaus, J., Koza, J., Kreiselmaier, I., Mohr, J., Mrowietz, U., Ockenfels, H. M., Orzechowski, H. D., Prinz, J., Reich, K., Rosenbach, T., Rosumeck, S., Schlaeger, M., Schmid-Ott, G., Sebastian, M., Streit, V., Weberschock, T., Rzany, B.
Gepubliceerd in 2007